SNHG12 and neoplasm: Results suggested that SNHG12 knockdown significantly suppressed the xenograft tumour growth, whereas inhibition of miR‐30a‐3p rescued the xenograft tumour growth comparing with the group treated with SNHG12‐KD cells and vehicle control (Figure 6B).